AFP and hepatocellular carcinoma: As shown in Fig. 5 and Table 2, PIVKA-II showed a significant ability in distinguishing AFP-negative HCC from healthy controls (AUCPIVKA-II = 0.88, P < 0.01) with a sensitivity of 78.33% and specificity of 91.3%, respectively.